データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
111119-28-9NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)CN)C(=O)OZRVZOBGMZWVJOS-VMXHOPILSA-N111119-28-9DTXSID20149506CHEMBL58763安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
使用Gly-Arg-Gly-Asp-Ser-Pro-Lys (RGD peptide) has been used-as a blocking peptide to inhibit integrin-fibronectin bindingin adhesion assay performed on porcine trophectoderm to study the influence of TGFβ (transforming growth factor) on cell adhesionfor incubation of MC3T3-E1 osteoblast cells to determine its effect on cell adhesion measured by AFM (atomic force microscopy)for the preparation of RGD.Flt23k.NR nanoparticlesto determine the involvement of RGD-integrin bonding in cell adhesion process
一般的な説明Gly-Arg-Gly-Asp-Ser-Pro-Lys is a RGD peptide. Naturally occurring RGD peptides, present in the ECM (extracellalar matrix) proteins, are involved in facilitating integrin-mediated cell adhesion to matrix proteins. RGD peptide is present as repeats in cell-adhesion protein, such as fibronectin and vitronectin. This tripeptide is recognized by cells by specific integrins (e.g. β1 , β3 , and β5 subunits), present on the cell surface and associated with the actin filament via the FA (focal adhesion)-complex.
現在のフィルター条件では反応記録がありません。
読み込み中…